References
- Rotermann M. Analysis of trends in the prevalence of cannabis use and related metrics in Canada. Health Rep. 2019 Jun 19;30(6):3–13.
- Accessed January 4th 2020. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations.html. cited 4 Jan 2020
- Hawley P, Gobbo M. Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada. Curr Oncol. 2019 Aug;26(4):e425–e432.
- Volkow ND, Swanson JM, Evins AE, et al. Effects of Cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016 Mar;73(3):292–297.
- Ford TC, Hayley AC, Downey LA, et al. Cannabis: an overview of its adverse acute and chronic effects and its implications. Curr Drug Abuse Rev. 2017;10(1):6–18.
- Crescioli G, Lombardi N, Bettiol A, et al. Adverse events following cannabis for medical use in Tuscany: an analysis of the Italian phytovigilance database. Br J Clin Pharmacol. 2020 Jan;86(1):106-120.
- Wang GS, Heard K, Roosevelt G. The unintended consequences of marijuana legalization. J Pediatr. 2017 Nov;190:12–13.
- Wilkinson ST, Yarnell S, Radhakrishnan R, et al. Marijuana legalization: impact on physicians and public health. Annu Rev Med. 2016;67:453–466.
- Huang Y-HJ, Zhang Z-F, Tashkin DP, et al. An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomarkers Prev. 2015;24(1):15–31.
- Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J. 2008;31(2):280–286.
- Leos-Toro C, Fong GT, Meyer SB, et al. Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth. Int J Drug Policy. 2019 Nov;73:24–31.
- Accessed December 31st 2019 https://www.statcan.gc.ca/eng/survey/household/3226. cited 31 Dec 2019
- Thomas S, Wannell B. Combining cycles of the Canadian community health survey. Health Rep. 2009 Mar;20(1):53–58.
- Abdel-Rahman O. Depression and suicidal ideation among patients with cancer in the united states: a population-based study. JCO Oncol Pract. 2020 Jul;16(7):e601-e609.
- Abdel-Rahman O. Socioeconomic predictors of suicide risk among cancer patients in the United States: a population-based study. Cancer Epidemiol. 2019 Dec;63:101601.
- Price C, Hemmingsson T, Lewis G, et al. Cannabis and suicide: longitudinal study. Br J Psychiatry. 2009 Dec;195(6):492–497.
- Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016 May;195:63–74.
- Lowry DE, Corsi DJ. Trends and correlates of cannabis use in Canada: a repeated cross-sectional analysis of national surveys from 2004 to 2017. CMAJ Open. 2020 July 1;8(3):E487–E495.
- Birdsall SM, Birdsall TC, Tims LA. The use of medical marijuana in cancer. Curr Oncol Rep. 2016 Jul;18(7):40.
- Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2015 Mar;65(2):109–122.
- Chayasirisobhon S. Cannabis and neuropsychiatric disorders: an updated review. Acta Neurol Taiwan. 2019 Jun 15;28(2):27–39.
- Solowij N, Broyd S, Greenwood LM, et al. A randomised controlled trial of vaporised Delta(9)-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17–35.
- MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018 Mar;49:12–19.